<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.sarg.dev/index.php?action=history&amp;feed=atom&amp;title=Tetryzoline</id>
	<title>Tetryzoline - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.sarg.dev/index.php?action=history&amp;feed=atom&amp;title=Tetryzoline"/>
	<link rel="alternate" type="text/html" href="https://wiki.sarg.dev/index.php?title=Tetryzoline&amp;action=history"/>
	<updated>2026-06-20T13:28:04Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wiki.sarg.dev/index.php?title=Tetryzoline&amp;diff=515838&amp;oldid=prev</id>
		<title>imported&gt;Blakegripling ph: /* Society and culture */ rmv pop culture cruft</title>
		<link rel="alternate" type="text/html" href="https://wiki.sarg.dev/index.php?title=Tetryzoline&amp;diff=515838&amp;oldid=prev"/>
		<updated>2025-10-07T23:33:08Z</updated>

		<summary type="html">&lt;p&gt;&lt;span class=&quot;autocomment&quot;&gt;Society and culture: &lt;/span&gt; rmv pop culture cruft&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Short description|Chemical compound}}&lt;br /&gt;
{{cs1 config|name-list-style=vanc}}&lt;br /&gt;
{{Infobox drug&lt;br /&gt;
| drug_name         =&lt;br /&gt;
| INN               =&lt;br /&gt;
| type              =&amp;lt;!-- empty --&amp;gt;&lt;br /&gt;
| IUPAC_name        = (&amp;#039;&amp;#039;RS&amp;#039;&amp;#039;)-2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1&amp;#039;&amp;#039;H&amp;#039;&amp;#039;-imidazole&lt;br /&gt;
| image             = Tetrahydrozoline-2D-skeletal.svg&lt;br /&gt;
| alt               = &lt;br /&gt;
| caption           =&lt;br /&gt;
| Verifiedfields = changed&lt;br /&gt;
| verifiedrevid = 470604535&lt;br /&gt;
&amp;lt;!-- Clinical data --&amp;gt;&lt;br /&gt;
| pronounce         =&lt;br /&gt;
| tradename         = &lt;br /&gt;
| Drugs.com         = &lt;br /&gt;
| MedlinePlus       = &lt;br /&gt;
| pregnancy_AU      = &amp;lt;!-- A/B1/B2/B3/C/D/X --&amp;gt;&lt;br /&gt;
| pregnancy_AU_comment = &lt;br /&gt;
| pregnancy_US      = &amp;lt;!-- A/B/C/D/X/N --&amp;gt;&lt;br /&gt;
| pregnancy_category= &lt;br /&gt;
| routes_of_administration = &lt;br /&gt;
| legal_AU = &amp;lt;!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--&amp;gt;&lt;br /&gt;
| legal_AU_comment =&lt;br /&gt;
| legal_BR =  &amp;lt;!-- OTC, A1, A2, A3, B1, B2, C1, C2, C3, C4, C5, D1, D2, E, F--&amp;gt;&lt;br /&gt;
| legal_BR_comment =&lt;br /&gt;
| legal_CA = &amp;lt;!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII --&amp;gt;&lt;br /&gt;
| legal_DE = &amp;lt;!-- Anlage I, II, III --&amp;gt;&lt;br /&gt;
| legal_NZ = &amp;lt;!-- Class A, B, C --&amp;gt;&lt;br /&gt;
| legal_UK = &amp;lt;!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM / Class A, B, C --&amp;gt;&lt;br /&gt;
| legal_US = &amp;lt;!-- OTC/Rx-only/Schedule I, II, III, IV, V --&amp;gt;&lt;br /&gt;
| legal_UN = &amp;lt;!-- N I, II, III, IV / P I, II, III, IV--&amp;gt;&lt;br /&gt;
| legal_status      = &amp;lt;!-- Free text --&amp;gt;&lt;br /&gt;
&amp;lt;!-- Pharmacokinetic data --&amp;gt;&lt;br /&gt;
| bioavailability   = &lt;br /&gt;
| protein_bound     = &lt;br /&gt;
| metabolism        = &lt;br /&gt;
| metabolites       =&lt;br /&gt;
| onset             = &lt;br /&gt;
| elimination_half-life = &lt;br /&gt;
| duration_of_action =&lt;br /&gt;
| excretion         = &lt;br /&gt;
&amp;lt;!-- Identifiers --&amp;gt;&lt;br /&gt;
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}&lt;br /&gt;
| ChemSpiderID = 5226&lt;br /&gt;
| KEGG_Ref = {{keggcite|correct|kegg}}&lt;br /&gt;
| KEGG = D08578&lt;br /&gt;
| ChEMBL_Ref = {{ebicite|correct|EBI}}&lt;br /&gt;
| ChEMBL = 1266&lt;br /&gt;
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}&lt;br /&gt;
| StdInChI = 1S/C13H16N2/c1-2-6-11-10(4-1)5-3-7-12(11)13-14-8-9-15-13/h1-2,4,6,12H,3,5,7-9H2,(H,14,15)&lt;br /&gt;
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}&lt;br /&gt;
| StdInChIKey = BYJAVTDNIXVSPW-UHFFFAOYSA-N&lt;br /&gt;
| CAS_number        = 84-22-0&lt;br /&gt;
| PubChem = 5419&lt;br /&gt;
| UNII_Ref = {{fdacite|correct|FDA}}&lt;br /&gt;
| UNII = S9U025Y077&lt;br /&gt;
| ChEBI_Ref = {{ebicite|correct|EBI}}&lt;br /&gt;
| ChEBI = 28674&lt;br /&gt;
| class             = &lt;br /&gt;
| ATCvet            = &lt;br /&gt;
| ATC_prefix        = R01&lt;br /&gt;
| ATC_suffix        = AA06&lt;br /&gt;
| ATC_supplemental  = {{ATC|S01|GA02}}&lt;br /&gt;
| DrugBank          = &lt;br /&gt;
&amp;lt;!-- Chemical and physical data --&amp;gt;&lt;br /&gt;
| C=13|H=16|N=2&lt;br /&gt;
| SMILES = N\1=C(\NCC/1)C3c2ccccc2CCC3&lt;br /&gt;
&amp;lt;!-- | Appearance =solid, crystalline&amp;lt;ref name=&amp;quot;:mer&amp;quot; /&amp;gt; --&amp;gt;&lt;br /&gt;
| melting_point     = 117-119&lt;br /&gt;
| melting_notes     = &amp;lt;ref&amp;gt;{{Cite patent| country = US | number = 2731471 | inventor = Synerholm M, Jules LH, Sahyun M | title = Imidazoline Derivatives | gdate = 17 January 1956 | assign1 = Sahyun Laboratories | postscript = . }}&amp;lt;/ref&amp;gt; {{convert|256|-|257|C|F}} for [[Hydrochloride|HCl]]-salt&amp;lt;ref name=&amp;quot;:mer&amp;quot;&amp;gt;{{Cite book | vauthors = Budavari S, O&amp;#039;Neil M, Smith A, Heckelman P, Obenchain J |title=The Merck Index | publisher = Chapman &amp;amp; Hall Electronic Publishing Division |year=2000 |edition= 12th |location=Whitehouse Station, NJ, United States |page=1453 |oclc=46987702 | isbn = 978-1-58488-129-2 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
| solubility =Very soluble in water and ethanol, slightly soluble in chloroform and insoluble in diethylether&amp;lt;ref name=&amp;quot;:mer&amp;quot; /&amp;gt;&lt;br /&gt;
| sol_units = &amp;amp;nbsp;&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;!-- Definition and medical uses --&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Tetryzoline&amp;#039;&amp;#039;&amp;#039; ([[International Nonproprietary Name|INN]]),&amp;lt;ref name=WHOINN/&amp;gt; also known as &amp;#039;&amp;#039;&amp;#039;tetrahydrozoline&amp;#039;&amp;#039;&amp;#039;, is a drug used in some over-the-counter [[eye drop]]s and [[nasal spray]]s. &amp;lt;!-- Society and culture --&amp;gt;Tetryzoline was patented in 1954, and came into medical use in 1959.&amp;lt;ref name=Fis2006&amp;gt;{{cite book | vauthors = Fischer J, Ganellin CR |title=Analogue-based Drug Discovery |date=2006 |publisher=John Wiley &amp;amp; Sons |isbn=978-3-527-60749-5  |page=552 |url=https://books.google.com/books?id=FjKfqkaKkAAC&amp;amp;pg=PA552 |language=en}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Side effects==&lt;br /&gt;
Tetryzoline eye drops may cause blurred vision, eye irritation and [[dilated pupils]].&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite web|url=https://www.nlm.nih.gov/toxnet/index.html|title=Tetrahydrozoline|website=toxnet.nlm.nih.gov|archive-url=https://web.archive.org/web/20170103190214/https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+7471|archive-date=2017-01-03|url-status=live|access-date=2018-09-05}}&amp;lt;/ref&amp;gt; Tetryzoline is not suitable for prolonged use as its vasoconstrictive effects within the eye eventually decrease or stop. If tolerance to the drug has developed, ceasing its use may cause a rebound effect and &amp;#039;&amp;#039;increase&amp;#039;&amp;#039; redness of the eyes — ⁠a vasodilatory effect.&amp;lt;ref&amp;gt;{{cite journal | vauthors = McLaurin E, Cavet ME, Gomes PJ, Ciolino JB | title = Brimonidine Ophthalmic Solution 0.025% for Reduction of Ocular Redness: A Randomized Clinical Trial | journal = Optometry and Vision Science | volume = 95 | issue = 3 | pages = 264–271 | date = March 2018 | pmid = 29461408 | pmc = 5839712 | doi = 10.1097/OPX.0000000000001182 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Intranasal use of tetryzoline may cause transient burning, stinging, or dryness of the [[mucosa]] and sneezing. Prolonged intranasal use often causes opposite effects in the form of [[rebound congestion]] with effects such as chronic redness, swelling and [[rhinitis]]. Prolonged use thus may result in overuse of the drug.&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In children, it might cause profound sedation.&amp;lt;ref&amp;gt;{{Cite web |title=Tetryzoline |url=https://go.drugbank.com/drugs/DB06764 |access-date=2022-09-15 |website=go.drugbank.com}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=== Overdose ===&lt;br /&gt;
Overdose most often causes [[slow heart rate]]. [[Respiratory depression]], [[low blood pressure]], [[constricted pupils]], [[hypothermia]], brief episodes of [[high blood pressure]],&amp;lt;ref name=&amp;quot;:1&amp;quot;&amp;gt;{{cite journal | vauthors = Al-Abri SA, Yang HS, Olson KR | title = Unintentional pediatric ophthalmic tetrahydrozoline ingestion: case files of the medical toxicology fellowship at the University of California, San Francisco | journal = Journal of Medical Toxicology | volume = 10 | issue = 4 | pages = 388–91 | date = December 2014 | pmid = 24760708 | pmc = 4252297 | doi = 10.1007/s13181-014-0400-9 }}&amp;lt;/ref&amp;gt; drowsiness, headaches and vomiting may also occur.&amp;lt;ref name=&amp;quot;:2&amp;quot; /&amp;gt; In serious cases some of these effects may result in [[circulatory shock]].&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt; Most often overdoses occur in children who have ingested the drug.&amp;lt;ref name=&amp;quot;:1&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
There is no antidote for tetryzoline or other similar imidazoline analogue poisoning, but the [[Symptomatic treatment|symptoms can be alleviated]]. With treatment, death is rare.&amp;lt;ref name=&amp;quot;:4&amp;quot;&amp;gt;{{cite journal | vauthors = Carr ME, Engebretsen KM, Ho B, Anderson CP | title = Tetrahydrozoline (Visine®) concentrations in serum and urine during therapeutic ocular dosing: a necessary first step in determining an overdose | journal = Clinical Toxicology | volume = 49 | issue = 9 | pages = 810–4 | date = November 2011 | pmid = 21972870 | doi = 10.3109/15563650.2011.615064 | s2cid = 20238499 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Pharmacology ==&lt;br /&gt;
&lt;br /&gt;
=== Pharmacodynamics ===&lt;br /&gt;
Tetryzoline is an [[Alpha-adrenergic agonist|alpha agonist]] for the [[alpha-1 receptor|alpha-1]] and [[Alpha-2 adrenergic receptor|alpha-2 receptors]].&amp;lt;ref&amp;gt;{{Cite web |title=Tetryzoline |url=https://go.drugbank.com/drugs/DB06764 |access-date=2022-12-21 |website=go.drugbank.com}}&amp;lt;/ref&amp;gt; This action relieves the redness of the eye caused by minor ocular irritants. Moreover, to treat [[allergic conjunctivitis]], tetryzoline can be combined in a solution with [[antazoline]].&amp;lt;ref name=&amp;quot;Castillo&amp;quot;&amp;gt;{{cite journal|vauthors=Castillo M, Scott NW, Mustafa MZ, Mustafa MS, Azuara-Blanco A|date=June 2015|title=Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis|url=http://aura.abdn.ac.uk/bitstream/2164/6048/1/Castillo_et_al_2015_The_Cochrane_Library.pdf|journal=The Cochrane Database of Systematic Reviews|volume=2015|issue=6|article-number=CD009566|doi=10.1002/14651858.CD009566.pub2|pmid=26028608|pmc=10616535 |hdl-access=free|hdl=2164/6048}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=== Pharmacokinetics ===&lt;br /&gt;
In a healthy person, the [[biological half-life]] of tetryzoline is approximately 6&amp;amp;nbsp;hours, and it is excreted in urine, chemically unchanged, at least in part. In one study, 10 people were given two drops of 0.5&amp;amp;nbsp;mg/mL of tetryzoline eye drops (0.025–0.05&amp;amp;nbsp;mg) at 0&amp;amp;nbsp;hrs, 4&amp;amp;nbsp;hrs, 8&amp;amp;nbsp;hrs, and 12&amp;amp;nbsp;hrs. Within a 24-hour time window, since the last dose of tetryzoline, the blood serum concentration of tetryzoline in the test subjects was 0.068-0.380 [[Nanogram|ng]]/mL and the urine concentration was 13–210&amp;amp;nbsp;ng/mL. Both the blood and the urine levels of tetryzoline reached their maximums approximately 9&amp;amp;nbsp;hrs after the last dose. These fluid-concentration levels correspond to normal ocular use of tetryzoline; thus, greater concentrations of tetryzoline in the blood and the urine of the user can indicate misuse of the drug or of poisoning with the drug.&amp;lt;ref name=&amp;quot;:4&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Chemistry==&lt;br /&gt;
Chemically, tetryzoline is a [[derivative (chemistry)|derivative]] of [[2-Imidazoline|imidazoline]]. It has two [[enantiomers]].&lt;br /&gt;
&lt;br /&gt;
==Society and culture==&lt;br /&gt;
&lt;br /&gt;
===Names===&lt;br /&gt;
Tetryzoline is the International Nonproprietary Name (INN).&amp;lt;ref name=WHOINN&amp;gt;{{cite web|url=https://www.who.int/medicines/publications/druginformation/innlists/RL03.pdf|title=International Non-Proprietary Names for Pharmaceutical Preparations. Recommended International Non-Proprietary Names: List 3|publisher=World Health Organization|page=474|archive-url=https://web.archive.org/web/20160911071542/http://www.who.int/medicines/publications/druginformation/innlists/RL03.pdf|archive-date=2016-09-11|url-status=live|access-date=30 August 2016}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Urban legend===&lt;br /&gt;
An [[urban legend]] suggests that tetryzoline can cause violent diarrhea if given orally, such as by putting a few drops of [[Visine]] in an unsuspecting person&amp;#039;s beverage. However, the actual results of the prank may be worse, varying from severe nausea and vomiting to seizures or a coma. Larger doses can cause death. Diarrhea is not a side effect.&amp;lt;ref&amp;gt;{{cite web | title=Visine Prank: Mickey Red Eyes | url=http://www.snopes.com/medical/myths/visine.asp  | work=Snopes | date=29 June 2009 | access-date=28 July 2010}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Criminal use===&lt;br /&gt;
In late August 2018, a [[South Carolina]] woman was charged with murdering her husband by putting eye drops containing tetryzoline in his drinking water. An autopsy found a high concentration of tetryzoline in his body.&amp;lt;ref&amp;gt;{{cite web | title=US wife accused of &amp;#039;fatally poisoning husband with eyedrops&amp;#039; | url=https://www.bbc.com/news/world-us-canada-45411562  | work=BBC | date=4 September 2018 | access-date=4 September 2018}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{citation&lt;br /&gt;
|url=https://abcnews.go.com/US/wireStory/police-woman-kills-husband-putting-eye-drops-water-57539122&lt;br /&gt;
|title=Police: Woman kills husband by putting eye drops in water&lt;br /&gt;
|date=August 31, 2018&lt;br /&gt;
|publisher=Associated Press}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{cite news | vauthors = Connelly E |title=Wife admits fatally poisoning &amp;#039;unfaithful&amp;#039; hubby with eye drops: cops |url=https://nypost.com/2018/09/01/wife-admits-fatally-poisoning-hubby-with-eye-drops-cops/ |access-date=3 September 2018 |publisher=New York Post |date=1 September 2018 |archive-url=https://web.archive.org/web/20180902012243/https://nypost.com/2018/09/01/wife-admits-fatally-poisoning-hubby-with-eye-drops-cops/ |archive-date=2018-09-02|url-status=live|language=en |format=Newspaper}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Tetryzoline has been used as a [[date rape drug]] in a number of cases due to its ability to cause dizziness and unconsciousness.&amp;lt;ref name=&amp;quot;:2&amp;quot;&amp;gt;{{cite journal | vauthors = Stillwell ME, Saady JJ | title = Use of tetrahydrozoline for chemical submission | journal = Forensic Science International | volume = 221 | issue = 1–3 | pages = e12-6 | date = September 2012 | pmid = 22554870 | doi = 10.1016/j.forsciint.2012.04.004 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In 2018, a 62 year-old woman in [[Pewaukee, Wisconsin]], died in an apparent overdose or suicide involving tetryzoline and other substances; in November 2023 her caregiver was convicted of [[Murder in United States law#Degrees|first-degree murder]], following the allegation that her death was caused by a water bottle laced with [[Visine]].&amp;lt;ref&amp;gt;{{cite web | url = https://abcnews.go.com/US/wisconsin-woman-arrested-accused-murdering-friend-eye-drops/story?id=78148517 | title = Wisconsin woman arrested, accused of murdering friend with eye drops: An investigation alleges the victim&amp;#039;s water bottle was laced with Visine. | work = ABC News | vauthors = Hutchinson B | date = 8 June 2021 }}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{cite web |url=https://abcnews.go.com/US/wisconsin-woman-found-guilty-killing-friend-eye-drops/story?id=104887158 |title=Wisconsin woman found guilty of killing friend with eye drops |vauthors=Deliso M |work=[[ABC News (United States)|ABC News]] |date=14 November 2023}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In 2019, a [[North Carolina]] paramedic was accused of using tetryzoline eye drops to cause the death of his wife. The blood sample results showed about 30–40 times higher than the therapeutic level of tetryzoline.&amp;lt;ref&amp;gt;{{Cite web | vauthors = Jacobo J, Stein B | date = 23 December 2019 |title=Paramedic accused of fatally poisoning his wife with ingredient found in eye drops: Prosecutors |url=https://abcnews.go.com/US/paramedic-accused-fatally-poisoning-wife-ingredient-found-eye/story?id=67883176 |access-date=2022-09-15 |website=ABC News |language=en}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite web | vauthors = Lee BY |title=How Visine Eye Drops In The Mouth Can Kill, Here Are Two Cases |url=https://www.forbes.com/sites/brucelee/2020/01/18/how-visine-eye-drops-in-the-mouth-can-kill-here-are-two-cases/ |date=18 January 2020 |access-date=2022-09-15 |website=Forbes |language=en}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
{{Adrenergic receptor modulators}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Alpha1-adrenergic agonists]]&lt;br /&gt;
[[Category:Alpha2-adrenergic agonists]]&lt;br /&gt;
[[Category:Imidazolines]]&lt;br /&gt;
[[Category:Tetralins]]&lt;br /&gt;
[[Category:Topical decongestants]]&lt;br /&gt;
[[Category:Vasoconstrictors]]&lt;/div&gt;</summary>
		<author><name>imported&gt;Blakegripling ph</name></author>
	</entry>
</feed>